Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumours, preventing the advance to secondary stage cancers, according to pharmacy researchers at the University of Sydney. [ + ]

QRxPharma (ASX:QRX) has completed two phase 1 trials of its MoxDuo CR dual-opioid tablets, and revealed some positive pharmacokinetic results. [ + ]

NSW-based biotech Sirtex Medical (ASX:SRX) said Q3 dose sales of its SIR-Spheres microspheres liver cancer treatment a record grew 34% year-on-year. [ + ]

Gliolan, a drug licensed to Melbourne's STA which has the ability to make brain tumours glow red during neurosurgery, has been granted orphan drug status by the TGA. [ + ]

A Murdoch University PhD candidate has won a $4500 scholarship to develop diagnostic tests for a pine tree pest. [ + ]

Warmer water temperatures can greatly increase the reproductive capacity of the widely distributed pest fish species Gambusia, or mosquito fish, a new study has found. [ + ]

Last week's opening of the Hawkesbury Institute for the Environment at the University of Western Sydney provides Australia with a world-class research institute to tackle the impacts of climate change. [ + ]

Dr Reddy's Laboratories has submitted an EU marketing authorisation application covering partner Alchemia's (ASX:ACL) fondaparinux anticoagulant. [ + ]

Academics and student researchers can benefit from a new web-based application for performing qualitative analyses using Leximancer, a software platform developed by the Institute for Social Science’s Dr Andrew Smith and his team at The University of Queensland. [ + ]

Research from The University of Western Australia (UWA) has discovered that plants appear to react to sounds and may even make clicking noises to communicate with each other. [ + ]

An international project to test the accuracy of climate modelling is now looking at how well current models can recreate past climates, in order to asset their ability to predict future climate change. [ + ]

A curative treatment for type 1 diabetes will come under the microscope as part of a new study by researchers from Flinders University. [ + ]

AusIndustry invites those interested in the new Clean Technology Investment Programs to attend an information session to learn about the programs and how to apply. [ + ]

Phosphagenics (ASX:POH) has signed a deal to license two anti-ageing products formulated for the Indian market to Intas Pharmaceuticals. [ + ]

Clunivel has reached an in-principle agreement with the US Food and Drug Administration to accelerate the phase III trials of Scenesse for the treatment of erythropoietic protoporphyria (EPP). [ + ]